{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:18:24Z","timestamp":1794917904254,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":1053,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1186\/s13613-023-01222-w","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T07:02:11Z","timestamp":1701759731000},"page":"121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prolonged vs intermittent intravenous infusion of \u03b2-lactam antibiotics for patients with sepsis: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis"],"prefix":"10.1016","volume":"13","author":[{"given":"Xiaoming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1443-7148","authenticated-orcid":false,"given":"Zhengying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1186\/s13613-023-01222-w_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis","volume":"24","author":"Bauer","year":"2020","journal-title":"Crit Care"},{"issue":"10219","key":"10.1186\/s13613-023-01222-w_bb0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1186\/s13613-023-01222-w_bb0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/CCM.0000000000005804","article-title":"Surviving sepsis campaign","volume":"51","author":"Dellinger","year":"2023","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1186\/s13613-023-01222-w_bb0025","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/CCM.0000000000003119","article-title":"The surviving sepsis campaign bundle: 2018 update","volume":"46","author":"Levy","year":"2018","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1186\/s13613-023-01222-w_bb0030","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1039\/D1MD00200G","article-title":"beta-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates","volume":"12","author":"Mora-Ochomogo","year":"2021","journal-title":"RSC Med Chem"},{"issue":"1","key":"10.1186\/s13613-023-01222-w_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1186\/s13613-023-01222-w_bb0040","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1186\/s13613-023-01222-w_bb0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13054-018-2155-1","article-title":"Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients","volume":"22","author":"Veiga","year":"2018","journal-title":"Crit Care"},{"issue":"6","key":"10.1186\/s13613-023-01222-w_bb0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/QCO.0000000000000681","article-title":"Prolonged infusion of beta-lactam antibiotics for gram-negative infections: rationale and evidence base","volume":"33","author":"Abdul-Aziz","year":"2020","journal-title":"Curr Opin Infect Dis"},{"issue":"11","key":"10.1186\/s13613-023-01222-w_bb0055","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1186\/s13613-023-01222-w_bb0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2110-5820-2-37","article-title":"Continuous beta-lactam infusion in critically ill patients: the clinical evidence","volume":"2","author":"Abdul-Aziz","year":"2012","journal-title":"Ann Intensive Care"},{"key":"10.1186\/s13613-023-01222-w_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40560-020-00490-z","article-title":"Prolonged versus intermittent beta-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials","volume":"8","author":"Kondo","year":"2020","journal-title":"J Intensive Care"},{"issue":"1","key":"10.1186\/s13613-023-01222-w_bb0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1473-3099(17)30615-1","article-title":"Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials","volume":"18","author":"Vardakas","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1186\/s13613-023-01222-w_bb0075","doi-asserted-by":"crossref","first-page":"154170","DOI":"10.1016\/j.jcrc.2022.154170","article-title":"The clinical and paraclinical effectiveness of four-hour infusion vs half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: an assessor-blinded randomized clinical trial","volume":"73","author":"Mirjalili","year":"2023","journal-title":"J Crit Care"},{"issue":"2","key":"10.1186\/s13613-023-01222-w_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jama.2023.10598","article-title":"Continuous vs intermittent meropenem administration in critically ill patients with sepsis: the MERCY randomized clinical trial","volume":"330","author":"Monti","year":"2023","journal-title":"JAMA"},{"issue":"7","key":"10.1186\/s13613-023-01222-w_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1186\/s13613-023-01222-w_bb0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"7414","key":"10.1186\/s13613-023-01222-w_bb0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"8","key":"10.1186\/s13613-023-01222-w_bb0100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1186\/s13613-023-01222-w_bb0105","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00134-015-4188-0","article-title":"Beta-lactam infusion in severe sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis","volume":"42","author":"Abdul-Aziz","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-023-01222-w_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1186\/s13613-023-01222-w_bb0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3 rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1186\/s13613-023-01222-w_bb0120","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/cc11405","article-title":"Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial","volume":"16","author":"Chytra","year":"2012","journal-title":"Crit Care"},{"issue":"2","key":"10.1186\/s13613-023-01222-w_bb0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/cid\/cis856","article-title":"Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial","volume":"56","author":"Dulhunty","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1186\/s13613-023-01222-w_bb0130","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1164\/rccm.201505-0857OC","article-title":"A multicenter randomized trial of continuous versus intermittent beta-lactam infusion in severe sepsis","volume":"192","author":"Dulhunty","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1186\/s13613-023-01222-w_bb0135","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijantimicag.2006.02.020","article-title":"Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients","volume":"28","author":"Rafati","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1186\/s13613-023-01222-w_bb0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jac\/dkl478","article-title":"Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study","volume":"59","author":"Roberts","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1186\/s13613-023-01222-w_bb0145","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4103\/0366-6999.205859","article-title":"Pharmacokinetic and pharmacodynamic efficacies of continuous versus intermittent administration of meropenem in patients with severe sepsis and septic shock: a prospective randomized pilot study","volume":"130","author":"Zhao","year":"2017","journal-title":"Chin Med J"},{"issue":"9","key":"10.1186\/s13613-023-01222-w_bb0150","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jiac.2023.05.008","article-title":"Clinical efficacy and safety of prolonged versus intermittent administration of antipseudomonal beta-lactam antibiotics in adults with severe acute infections: a meta-analysis of randomized controlled trials","volume":"29","author":"Kiran","year":"2023","journal-title":"J Infect Chemother"},{"issue":"2","key":"10.1186\/s13613-023-01222-w_bb0155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/CCM.0000000000002836","article-title":"Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis","volume":"46","author":"Rhodes","year":"2018","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1186\/s13613-023-01222-w_bb0160","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1164\/rccm.201601-0024OC","article-title":"Continuous versus intermittent beta-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials","volume":"194","author":"Roberts","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1186\/s13613-023-01222-w_bb0165","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1186\/s13613-023-01222-w_bb0170","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s40265-023-01893-6","article-title":"Extended and continuous infusion of novel protected beta-lactam antibiotics: a narrative review","volume":"83","author":"Venuti","year":"2023","journal-title":"Drugs"},{"issue":"2","key":"10.1186\/s13613-023-01222-w_bb0175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jama.2023.6483","article-title":"Do prolonged infusions of beta-lactam antibiotics improve outcomes in critically Ill patients with sepsis?","volume":"330","author":"Shappell","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1186\/s13613-023-01222-w_bb0180","first-page":"63","article-title":"A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent beta-lactam antibiotic infusion in critically ill patients with sepsis: BLING III","volume":"21","author":"Lipman","year":"2019","journal-title":"Crit Care Resusc"},{"issue":"Suppl 1","key":"10.1186\/s13613-023-01222-w_bb0185","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1086\/344653","article-title":"Prevention of resistance: a goal for dose selection for antimicrobial agents","volume":"36","author":"Drusano","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1186\/s13613-023-01222-w_bb0190","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3390\/antibiotics11121839","article-title":"beta-lactam dosing in critical patients: a narrative review of optimal efficacy and the prevention of resistance and toxicity","volume":"11","author":"Pereira","year":"2022","journal-title":"Antibiotics"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-023-01222-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-023-01222-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025005849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025005849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-023-01222-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:44:32Z","timestamp":1776671072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025005849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"alternative-id":["S2110582025005849"],"URL":"https:\/\/doi.org\/10.1186\/s13613-023-01222-w","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolonged vs intermittent intravenous infusion of \u03b2-lactam antibiotics for patients with sepsis: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-023-01222-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The Author(s) 2023. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"121"}}